Cargando…

Factors predicting long-term comorbidities in patients with Cushing’s syndrome in remission

PURPOSE: In Cushing’s syndrome, comorbidities often persist after remission of glucocorticoid excess. Here, we aim to identify factors predicting long-term comorbidities in patients with Cushing’s syndrome in remission. METHODS: In a retrospective cross-sectional study, 118 patients with Cushing’s s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schernthaner-Reiter, Marie Helene, Siess, Christina, Gessl, Alois, Scheuba, Christian, Wolfsberger, Stefan, Riss, Philipp, Knosp, Engelbert, Luger, Anton, Vila, Greisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6453862/ https://www.ncbi.nlm.nih.gov/pubmed/30467627 http://dx.doi.org/10.1007/s12020-018-1819-6

Ejemplares similares

MON-318 Acute, Life-Threatening and Perioperative Complications in Cushing’s Syndrome: Predictors and Outcomes
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2020)

Long-Term Corticotroph Function Following Cure of Cushing’s Syndrome
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

LBMON175 Nadir Growth Hormone Concentrations In Patients With Acromegaly Relate To Disease Activity, Glucose Metabolism, BMI And Sex
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2022)

SAT-431 Parameters of Glucose Metabolism Independently Predict Post Glucose Load Growth Hormone Concentrations in Patients with Acromegaly
por: Micko, Alexander, et al.
Publicado: (2019)

Ectopic Cushing’s syndrome in a patient with inferior petrosal sinus sampling indicating pituitary‐dependent ACTH secretion
por: Micko, Alexander, et al.
Publicado: (2019)

The Interaction of Insulin and Pituitary Hormone Syndromes
por: Schernthaner-Reiter, Marie Helene, et al.
Publicado: (2021)

MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas
por: Micko, Alexander S. G., et al.
Publicado: (2017)

Calcium-stimulated calcitonin - The “new standard” in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an “old test”
por: Niederle, Martin B., et al.
Publicado: (2018)

Perioperative Management of a Patient With Cushing Disease
por: Varlamov, Elena V, et al.
Publicado: (2022)

Response to Comment on: Vila et al. B-Type Natriuretic Peptide Modulates Ghrelin, Hunger, and Satiety in Healthy Men. Diabetes 2012;61:2592–2596
por: Vila, Greisa, et al.
Publicado: (2012)

MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals
por: Micko, Alexander S. G., et al.
Publicado: (2018)

Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves’ ophthalmopathy – a 1-year follow-up: study protocol for a randomized controlled trial
por: Brammen, Lindsay, et al.
Publicado: (2018)

Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome
por: Detomas, Mario, et al.
Publicado: (2022)

Optimizing MR imaging for intraoperative image guidance in sellar pathologies
por: Micko, Alexander, et al.
Publicado: (2020)

Remission in Cushing disease with cabergoline
por: Gopal, Raju, et al.
Publicado: (2008)

Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else
por: Cho, Anna, et al.
Publicado: (2022)

SUN-450 Comorbidities in 419 Patients with Cushing's Disease in Remission: A Swedish Nationwide Study
por: Papakokkinou, Eleni, et al.
Publicado: (2019)

Comorbidities in Cushing’s disease
por: Sharma, S. T., et al.
Publicado: (2015)

Endokrine und neuroendokrine Tumoren
por: Riss, Philipp, et al.
Publicado: (2021)

Insulin Resistance in Patients With Acromegaly
por: Vila, Greisa, et al.
Publicado: (2019)

Cushing Mortality in Remission: Not Out of the Woods
por: Kelsall, Alan, et al.
Publicado: (2022)

Adequately Adapted Insulin Secretion and Decreased Hepatic Insulin Extraction Cause Elevated Insulin Concentrations in Insulin Resistant Non-Diabetic Adrenal Incidentaloma Patients
por: Anderwald, Christian-Heinz, et al.
Publicado: (2013)

Challenging the osseous component of sphenoorbital meningiomas
por: Maschke, Svenja, et al.
Publicado: (2019)

Cholinergic Regulation of Ghrelin and Peptide YY Release May Be Impaired in Obesity
por: Maier, Christina, et al.
Publicado: (2008)

Remission with Cabergoline in Adolescent Boys with Cushing’s Disease
por: Güven, Ayla, et al.
Publicado: (2013)

Prophylactic “First-Step” Central Neck Dissection (Level 6) Does Not Increase Morbidity After (Total) Thyroidectomy
por: Selberherr, Andreas, et al.
Publicado: (2016)

Diabetes in the older patient: heterogeneity requires individualisation of therapeutic strategies
por: Schernthaner, Guntram, et al.
Publicado: (2018)

Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension
por: Fleseriu, Maria, et al.
Publicado: (2022)

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement
por: Widhalm, Georg, et al.
Publicado: (2013)

Mental Fatigue and Executive Dysfunction in Patients with Cushing's Syndrome in Remission
por: Papakokkinou, Eleni, et al.
Publicado: (2015)

Persisting Muscle Dysfunction in Cushing’s Syndrome Despite Biochemical Remission
por: Vogel, Frederick, et al.
Publicado: (2020)

Metabolic status in children with Cushing’s disease and its relationship with remission
por: Moszczyńska, Elżbieta, et al.
Publicado: (2023)

Is cushing's syndrome remission associated with diabetes regression? Analysis of a retrospective cohort of 108 patients with cushing's disease
por: Londero, Thizá Massaia, et al.
Publicado: (2015)

Widespread reductions of white matter integrity in patients with long-term remission of Cushing's disease
por: van der Werff, Steven J.A., et al.
Publicado: (2014)

Evaluation of procoagulant imbalance in Cushing’s syndrome after short- and long-term remission of disease
por: Ferrante, E., et al.
Publicado: (2021)

Whole-Body Insulin Sensitivity Rather than Body-Mass-Index Determines Fasting and Post-Glucose-Load Growth Hormone Concentrations
por: Anderwald, Christian-Heinz, et al.
Publicado: (2014)

Decreased Aerobic Exercise Capacity After Long-Term Remission From Cushing Syndrome: Exploration of Mechanisms
por: Roerink, Sean H P P, et al.
Publicado: (2019)

PMON163 Effect of Osilodrostat on Androgens and Adrenal Hormones in Patients With Cushing's Disease: Long-Term Findings From the Phase III, Prospective LINC 3 Study
por: Fleseriu, Maria, et al.
Publicado: (2022)

How radical is total parathyroidectomy in patients with renal hyperparathyroidism?
por: Burgstaller, Thomas, et al.
Publicado: (2018)

Applicability of a shortened interpretation model for intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism in an endemic goiter region
por: Riss, Philipp, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k4v712pktt58ofq67oo3imujfp